Saturday 17 October 2026 Export ATXI’s income statement to Excel — free account

Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 million. In the quarter to June 2026, EPS fell 290.9% and free cash flow fell 169.9%, each against the same quarter a year earlier.

0.43 0.00 0.00%

Follow ATXI

Alert me

Market cap: $680.0K
P/E: 0.0×
Fwd P/E: −0.4×
Dividend yield: —
F-score: n/a
Altman Z: −51.47
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(163.30%)	(99.26%)	(157.75%)	37.93%	+8 more TTM periods Free account
ROA Full definition →	(90.50%)	(57.80%)	(103.84%)	23.62%
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(488.05%)	(146.24%)	(158.79%)	32.57%
Average Days of Receivables Full definition →	—	—	—	—
Free Cash Flow per Share Full definition →	(0.42)	(0.33)	(0.59)	(0.55)
Free Cash Flow Full definition →	(1.38)	(1.08)	(1.83)	(1.74)
Other line items
Cash ROIC Full definition →	(55.12%)	(30.01%)	(39.11%)	(28.99%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.50	0.62	0.63	(2.32)
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.42)	(0.33)	(0.59)	(0.55)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly